• News
  • SAN DIEGO
  • Finance

Daily Digest

The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.

CareFusion Corp.: Company reported net income of $108 million, or 49 cents per share, for quarter ended Dec. 31.

Dexcom Inc: Company announced it will present at the Leerink Swann Global Healthcare Conference, Wednesday in New York City.

Isis Pharmaceuticals Inc.: Company announced it will present at the Leerink Swann Global Healthcare Conference, Thursday in New York City.

LifeVantage Corp.: Company reported net income of $209,000 for the quarter ended Dec. 31.

Orexigen Therapeutics Inc.: Company announced it will present at the 15th Annual BIO CEO & Investor Conference, Tuesday, and at the Leerink Swann Global Healthcare Conference, Wednesday, both in New York City.

Peregrine Semiconductor Corp: Company was downgraded to “market perform” from “outperform” by brokerage firm Oppenheimer & Co.

Servicenow Inc: SEC documents showed: Vice President David Schneider exercised options on 55,000 shares at $3 per share, and sold 55,000 shares at $29.41 to $29.85 per share on Tuesday; and CEO Frank Slootman sold 25,000 shares at $29.43 to $29.51 per share on Tuesday.

Viasat Inc: Company was upgraded to “buy” from “hold” by brokerage firm Needham & Co. The target price is $50 per share.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!